Successful transition from insulin to sulfonylurea treatment in an adult with permanent neonatal diabetes mellitus with a KCNJ11 mutation: A case report

被引:0
|
作者
O'Brien, C. [1 ]
Bell, M. [1 ]
Griffin, T. [1 ]
机构
[1] Galway Univ Hosp, Ctr Diabet Endocrinol & Metab, Galway, Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P44
引用
收藏
页码:105 / 105
页数:1
相关论文
共 50 条
  • [41] Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene
    Rajesh Joshi
    Ankur Phatarpekar
    World Journal of Pediatrics, 2011, 7 : 371 - 372
  • [42] TRANSIENT NEONATAL DIABETES MELLITUS IN PATIENTS WITH MUTATION OF ABCC8 AND KCNJ11 GENES
    Can, Ngoc T. B.
    Dung Chi Vu
    Bui, Thao P.
    Nguyen, Khanh N.
    Nguyen, Dat P.
    De Franco, Elisa
    Flanagan, Sarah
    Ellard, Sian
    Nguyen, Hoan T.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 268 - 268
  • [43] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2-initial and long-term response to sulfonylurea therapy
    Wagner, Verena M.
    Kremke, Britta
    Hiort, Olaf
    Flanagan, Sarah E.
    Pearson, Ewan R.
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (03) : 359 - 361
  • [44] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2—initial and long-term response to sulfonylurea therapy
    Verena M. Wagner
    Britta Kremke
    Olaf Hiort
    Sarah E. Flanagan
    Ewan R. Pearson
    European Journal of Pediatrics, 2009, 168 : 359 - 361
  • [45] Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene
    Joshi, Rajesh
    Phatarpekar, Ankur
    WORLD JOURNAL OF PEDIATRICS, 2011, 7 (04) : 371 - 372
  • [46] KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes
    Massa, O
    Iafusco, D
    D'Amato, E
    Gloyn, AL
    Hattersley, AT
    Pasquino, B
    Tonini, G
    Dammacco, F
    Zanette, G
    Meschi, F
    Porzio, O
    Bottazzo, G
    Crinó, A
    Lorini, R
    Cerutti, F
    Vanelli, M
    Barbetti, F
    HUMAN MUTATION, 2005, 25 (01) : 22 - 27
  • [47] Sulfonylurea Use During Entire Pregnancy in Diabetes Because of KCNJ11 Mutation: A Report of Two Cases
    Gaal, Zsolt
    Klupa, Tomasz
    Kantor, Irene
    Mlynarski, Wojciech
    Albert, Laszlo
    Tolloczko, Justyna
    Balogh, Istvan
    Czajkowski, Krzysztof
    Malecki, Maciej T.
    DIABETES CARE, 2012, 35 (06) : E40 - E40
  • [48] Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
    G. Tonini
    C. Bizzarri
    R. Bonfanti
    M. Vanelli
    F. Cerutti
    E. Faleschini
    F. Meschi
    F. Prisco
    E. Ciacco
    M. Cappa
    C. Torelli
    V. Cauvin
    S. Tumini
    D. Iafusco
    F. Barbetti
    Diabetologia, 2006, 49 : 2210 - 2213
  • [49] KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients
    Ioannou, Yiannis S.
    Ellard, Sian
    Hattersley, Andrew
    Skordis, Nicos
    PEDIATRIC DIABETES, 2011, 12 (02) : 133 - 137
  • [50] Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
    Tonini, G.
    Bizzarri, C.
    Bonfanti, R.
    Vanelli, M.
    Cerutti, F.
    Faleschini, E.
    Meschi, F.
    Prisco, F.
    Ciacco, E.
    Cappa, M.
    Torelli, C.
    Cauvin, V.
    Tumini, S.
    Iafusco, D.
    Barbetti, F.
    DIABETOLOGIA, 2006, 49 (09) : 2210 - 2213